色素-话题@MedSci

#色素#

654篇内容 | 6296人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1680828, encodeId=70b11680828bd, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Exp Dermatol ：类似黑色素瘤的基底细胞癌的皮肤镜特征, objectType=article, longId=738383, objectId=e5a2e3838337, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5a2e3838337, replyNumber=0, likeNumber=87, createdTime=2022-12-22, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5a2e3838337, moduleTitle=Exp Dermatol ：类似黑色素瘤的基底细胞癌的皮肤镜特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5a2e3838337)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680809, encodeId=c901168080951, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=ASCO：两种检查点抑制剂组合治疗皮肤黑色素瘤的疗效——系统回顾结果, objectType=article, longId=728226, objectId=c05ae282264e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c05ae282264e, replyNumber=0, likeNumber=84, createdTime=2023-04-17, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c05ae282264e, moduleTitle=ASCO：两种检查点抑制剂组合治疗皮肤黑色素瘤的疗效——系统回顾结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c05ae282264e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680806, encodeId=8f9616808068c, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=ASCO：四周的MPRbx可作为晚期黑色素瘤治疗反应的早期生物标志物, objectType=article, longId=728229, objectId=e1ace28229dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1ace28229dc, replyNumber=0, likeNumber=80, createdTime=2023-01-02, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1ace28229dc, moduleTitle=ASCO：四周的MPRbx可作为晚期黑色素瘤治疗反应的早期生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1ace28229dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680788, encodeId=bd1b1680e8852, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=JEADV：数字皮肤镜监测黑素细胞损害：两种结合静态和动态特征识别黑色素瘤的新方法, objectType=article, longId=300620, objectId=fcb53006201f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcb53006201f, replyNumber=0, likeNumber=102, createdTime=2022-08-13, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcb53006201f, moduleTitle=JEADV：数字皮肤镜监测黑素细胞损害：两种结合静态和动态特征识别黑色素瘤的新方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcb53006201f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680772, encodeId=ed9f1680e729f, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=JAMA子刊：掀起“谈痣色变”风的黑色素瘤与肾癌密不可分！46岁以下RCC患者都应该进行这些基因筛查！, objectType=article, longId=220370, objectId=c45f2203e030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c45f2203e030, replyNumber=0, likeNumber=87, createdTime=2022-06-25, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c45f2203e030, moduleTitle=JAMA子刊：掀起“谈痣色变”风的黑色素瘤与肾癌密不可分！46岁以下RCC患者都应该进行这些基因筛查！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c45f2203e030)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680827, encodeId=351a168082e4f, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=EJCB：王福俤团队揭示锌离子稳态调控黑色素细胞增殖新机制, objectType=article, longId=738461, objectId=299ee38461f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=299ee38461f3, replyNumber=0, likeNumber=60, createdTime=2023-02-10, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=299ee38461f3, moduleTitle=EJCB：王福俤团队揭示锌离子稳态调控黑色素细胞增殖新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=299ee38461f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680804, encodeId=95431680804a1, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Clin Nutrition: 骨骼肌在切除的III期恶性黑色素瘤的患者中具有预后意义, objectType=article, longId=726495, objectId=d831e2649564, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d831e2649564, replyNumber=0, likeNumber=88, createdTime=2022-08-29, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d831e2649564, moduleTitle=Clin Nutrition: 骨骼肌在切除的III期恶性黑色素瘤的患者中具有预后意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d831e2649564)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680822, encodeId=cd43168082214, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=JGH：硫唑嘌呤治疗不会导致炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险增加, objectType=article, longId=735611, objectId=29e0e3561170, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29e0e3561170, replyNumber=0, likeNumber=103, createdTime=2023-04-04, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29e0e3561170, moduleTitle=JGH：硫唑嘌呤治疗不会导致炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29e0e3561170)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680815, encodeId=7bab1680815e3, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=一文读懂！色素沉着绒毛结节性滑膜炎（PVNS）, objectType=article, longId=730943, objectId=596ee3094304, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=596ee3094304, replyNumber=0, likeNumber=114, createdTime=2022-09-02, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=596ee3094304, moduleTitle=一文读懂！色素沉着绒毛结节性滑膜炎（PVNS）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=596ee3094304)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680823, encodeId=274016808239f, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=J Cosmet Dermatol：皮内注射A型肉毒杆菌毒素并不能治疗紫外线照射引起的色素沉着, objectType=article, longId=735868, objectId=7925e35868b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7925e35868b3, replyNumber=0, likeNumber=79, createdTime=2023-07-12, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7925e35868b3, moduleTitle=J Cosmet Dermatol：皮内注射A型肉毒杆菌毒素并不能治疗紫外线照射引起的色素沉着, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7925e35868b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680773, encodeId=849a1680e73f9, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=细胞色素 P450 环氧合酶2J2保护肺动脉高压和肺缺血再灌注损伤, objectType=article, longId=220444, objectId=a46d220444aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a46d220444aa, replyNumber=0, likeNumber=82, createdTime=2022-10-21, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a46d220444aa, moduleTitle=细胞色素 P450 环氧合酶2J2保护肺动脉高压和肺缺血再灌注损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a46d220444aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680794, encodeId=f6d51680e9482, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Clin Cancer Res：比美替尼联合瑞博西林治疗NRAS突变的黑色素瘤, objectType=article, longId=301035, objectId=dece30103500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dece30103500, replyNumber=0, likeNumber=85, createdTime=2022-07-15, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dece30103500, moduleTitle=Clin Cancer Res：比美替尼联合瑞博西林治疗NRAS突变的黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dece30103500)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680813, encodeId=e965168081363, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=J Clin Oncol：Spartalizumab 联合达拉非尼和曲美替尼治疗黑色素瘤的疗效, objectType=article, longId=729628, objectId=bf1ee296289d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf1ee296289d, replyNumber=0, likeNumber=143, createdTime=2023-05-19, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf1ee296289d, moduleTitle=J Clin Oncol：Spartalizumab 联合达拉非尼和曲美替尼治疗黑色素瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf1ee296289d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680766, encodeId=9cb91680e6647, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Clin Cancer Res：3期coBRIM研究| 威罗非尼+帕博西尼治疗BRAFV600+ 晚期黑色素瘤的长期随访结果, objectType=article, longId=218363, objectId=b482218363b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b482218363b0, replyNumber=0, likeNumber=85, createdTime=2022-02-27, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b482218363b0, moduleTitle=Clin Cancer Res：3期coBRIM研究| 威罗非尼+帕博西尼治疗BRAFV600+ 晚期黑色素瘤的长期随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b482218363b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680799, encodeId=c88c1680e9978, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=AACR重磅之SPOTLIGHT203试验：瘤内注射BO-112联合帕博丽珠单抗对PD-1免疫治疗耐药的晚期黑色素瘤患者的疗效, objectType=article, longId=723987, objectId=2fc5e239870d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fc5e239870d, replyNumber=0, likeNumber=88, createdTime=2022-07-31, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fc5e239870d, moduleTitle=AACR重磅之SPOTLIGHT203试验：瘤内注射BO-112联合帕博丽珠单抗对PD-1免疫治疗耐药的晚期黑色素瘤患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fc5e239870d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680814, encodeId=78bd16808140d, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Nat Commun：科学家识别出驱动人类黑色素瘤发生的特定分子因素, objectType=article, longId=730853, objectId=19f5e3085306, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19f5e3085306, replyNumber=0, likeNumber=122, createdTime=2023-02-03, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19f5e3085306, moduleTitle=Nat Commun：科学家识别出驱动人类黑色素瘤发生的特定分子因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19f5e3085306)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680778, encodeId=7b761680e78a0, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Front Oncol：真实世界研究分析黑色素瘤患者抗PD-1治疗免疫相关不良事件与疗效的关系, objectType=article, longId=221570, objectId=2dff2215e066, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dff2215e066, replyNumber=0, likeNumber=136, createdTime=2022-06-09, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dff2215e066, moduleTitle=Front Oncol：真实世界研究分析黑色素瘤患者抗PD-1治疗免疫相关不良事件与疗效的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2dff2215e066)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680787, encodeId=9ade1680e8718, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=癌细胞竟学会“下毒”了！科学家首次发现黑色素瘤细胞分泌阿尔茨海默病“毒蛋白”，让星形胶质细胞促癌转移，并抑制小胶质细胞的吞噬功能, objectType=article, longId=300590, objectId=a118300590d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a118300590d8, replyNumber=0, likeNumber=96, createdTime=2022-03-29, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a118300590d8, moduleTitle=癌细胞竟学会“下毒”了！科学家首次发现黑色素瘤细胞分泌阿尔茨海默病“毒蛋白”，让星形胶质细胞促癌转移，并抑制小胶质细胞的吞噬功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a118300590d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680820, encodeId=75dc1680820bf, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lancet Oncol：阿特珠单抗+Cobimetinib+Vemurafenib治疗CNS转移的黑色素瘤, objectType=article, longId=735293, objectId=8390e3529363, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8390e3529363, replyNumber=0, likeNumber=71, createdTime=2023-05-10, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8390e3529363, moduleTitle=Lancet Oncol：阿特珠单抗+Cobimetinib+Vemurafenib治疗CNS转移的黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8390e3529363)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680790, encodeId=b3861680e9013, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=刘业强教授：黑色素瘤病理诊断+临床实践指南全新解读, objectType=article, longId=300733, objectId=666f300e3311, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=666f300e3311, replyNumber=0, likeNumber=53, createdTime=2022-12-16, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=666f300e3311, moduleTitle=刘业强教授：黑色素瘤病理诊断+临床实践指南全新解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=666f300e3311)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

色素

2020-05-29

sunylz (审核中...)

前往app查看评论内容

#色素#

Exp Dermatol ：类似黑色素瘤的基底细胞癌的皮肤镜特征

2022-12-22

sunylz (审核中...)

前往app查看评论内容

#色素#

ASCO：两种检查点抑制剂组合治疗皮肤黑色素瘤的疗效——系统回顾结果

2023-04-17

sunylz (审核中...)

前往app查看评论内容

#色素#

ASCO：四周的MPRbx可作为晚期黑色素瘤治疗反应的早期生物标志物

2023-01-02

sunylz (审核中...)

前往app查看评论内容

#色素#

JEADV：数字皮肤镜监测黑素细胞损害：两种结合静态和动态特征识别黑色素瘤的新方法

2022-08-13

sunylz (审核中...)

前往app查看评论内容

#色素#

JAMA子刊：掀起“谈痣色变”风的黑色素瘤与肾癌密不可分！46岁以下RCC患者都应该进行这些基因筛查！

2022-06-25

sunylz (审核中...)

前往app查看评论内容

#色素#

EJCB：王福俤团队揭示锌离子稳态调控黑色素细胞增殖新机制

2023-02-10

sunylz (审核中...)

前往app查看评论内容

#色素#

Clin Nutrition: 骨骼肌在切除的III期恶性黑色素瘤的患者中具有预后意义

2022-08-29

sunylz (审核中...)

前往app查看评论内容

#色素#

JGH：硫唑嘌呤治疗不会导致炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险增加

2023-04-04

sunylz (审核中...)

前往app查看评论内容

#色素#

一文读懂！色素沉着绒毛结节性滑膜炎（PVNS）

2022-09-02

sunylz (审核中...)

前往app查看评论内容

#色素#

J Cosmet Dermatol：皮内注射A型肉毒杆菌毒素并不能治疗紫外线照射引起的色素沉着

2023-07-12

sunylz (审核中...)

前往app查看评论内容

#色素#

细胞色素 P450 环氧合酶2J2保护肺动脉高压和肺缺血再灌注损伤

2022-10-21

sunylz (审核中...)

前往app查看评论内容

#色素#

Clin Cancer Res：比美替尼联合瑞博西林治疗NRAS突变的黑色素瘤

2022-07-15

sunylz (审核中...)

前往app查看评论内容

#色素#

J Clin Oncol：Spartalizumab 联合达拉非尼和曲美替尼治疗黑色素瘤的疗效

2023-05-19

sunylz (审核中...)

前往app查看评论内容

#色素#

Clin Cancer Res：3期coBRIM研究| 威罗非尼+帕博西尼治疗BRAFV600+ 晚期黑色素瘤的长期随访结果

2022-02-27

sunylz (审核中...)

前往app查看评论内容

#色素#

AACR重磅之SPOTLIGHT203试验：瘤内注射BO-112联合帕博丽珠单抗对PD-1免疫治疗耐药的晚期黑色素瘤患者的疗效

2022-07-31

sunylz (审核中...)

前往app查看评论内容

#色素#

Nat Commun：科学家识别出驱动人类黑色素瘤发生的特定分子因素

2023-02-03

sunylz (审核中...)

前往app查看评论内容

#色素#

Front Oncol：真实世界研究分析黑色素瘤患者抗PD-1治疗免疫相关不良事件与疗效的关系

2022-06-09

sunylz (审核中...)

前往app查看评论内容

#色素#

癌细胞竟学会“下毒”了！科学家首次发现黑色素瘤细胞分泌阿尔茨海默病“毒蛋白”，让星形胶质细胞促癌转移，并抑制小胶质细胞的吞噬功能

2022-03-29

sunylz (审核中...)

前往app查看评论内容

#色素#

Lancet Oncol：阿特珠单抗+Cobimetinib+Vemurafenib治疗CNS转移的黑色素瘤

2023-05-10

sunylz (审核中...)

前往app查看评论内容

#色素#

刘业强教授：黑色素瘤病理诊断+临床实践指南全新解读

2022-12-16

科室
- - 订阅+
  - 更多科室
工具
服务